VION Biosciences
Platform company that acquires and operates life-science businesses providing reagents, custom chemical and biopharmaceutical manufacturing, assay and diagnostic development, and laboratory products. Offers end-to-end support across discovery, formulation/manufacture, and commercial distribution, with stated capabilities in lipid nanoparticle design, cGMP production, immunoassays, reagent supply, and growth by acquisition of specialty lipid, immunoassay, and assay companies in 2024–2025.
Industries
Nr. of Employees
large (251-1000)
Products
Molecular-grade deionized water
0.035 µm filtered, UV-sterilized deionized water for microbiological and molecular applications; provided with resistivity, TOC, endotoxin, and microbial specifications.
ACS reagent-grade deionized water
Deionized water meeting ACS reagent-grade purity with conductivity and UV absorbance specifications for analytical chemistry.
ASTM Type I ultrapure water
Ultrapure water conforming to ASTM Type I criteria for trace analysis and high-sensitivity instrumentation.
Xylene substitute (histology-grade clearing agent)
Clearing agent formulated as an alternative to xylene for tissue processing and mounting with reduced vapor exposure and compatibility with synthetic mounting media.
Sodium bicarbonate (bioreagent)
High-purity sodium bicarbonate powder for use as a buffering agent and pH regulator in laboratory applications.
Citric acid (anhydrous and monohydrate, bioreagent)
High-purity citric acid supplied as anhydrous and monohydrate forms with specification sheets for use in pharmaceuticals, cosmetics, and laboratory formulations.
Molecular-grade deionized water
0.035 µm filtered, UV-sterilized deionized water for microbiological and molecular applications; provided with resistivity, TOC, endotoxin, and microbial specifications.
ACS reagent-grade deionized water
Deionized water meeting ACS reagent-grade purity with conductivity and UV absorbance specifications for analytical chemistry.
ASTM Type I ultrapure water
Ultrapure water conforming to ASTM Type I criteria for trace analysis and high-sensitivity instrumentation.
Xylene substitute (histology-grade clearing agent)
Clearing agent formulated as an alternative to xylene for tissue processing and mounting with reduced vapor exposure and compatibility with synthetic mounting media.
Sodium bicarbonate (bioreagent)
High-purity sodium bicarbonate powder for use as a buffering agent and pH regulator in laboratory applications.
Citric acid (anhydrous and monohydrate, bioreagent)
High-purity citric acid supplied as anhydrous and monohydrate forms with specification sheets for use in pharmaceuticals, cosmetics, and laboratory formulations.
Services
Design and manufacture of lipid nanoparticles and custom lipids for nucleic-acid delivery, including formulation development and biodistribution support.
cGMP-compliant manufacturing and scale-up for biologics, reagents, and diagnostic materials with batch quality control and documentation.
Tailored antibody generation and immunoassay development, including assay design, validation support, and kit manufacture.
Contract formulation, precision powder blending, private-label chemical production, and assembly of laboratory and educational kits.
Design and manufacture of lipid nanoparticles and custom lipids for nucleic-acid delivery, including formulation development and biodistribution support.
cGMP-compliant manufacturing and scale-up for biologics, reagents, and diagnostic materials with batch quality control and documentation.
Tailored antibody generation and immunoassay development, including assay design, validation support, and kit manufacture.
Contract formulation, precision powder blending, private-label chemical production, and assembly of laboratory and educational kits.
Expertise Areas
- Lipid nanoparticle formulation and drug delivery
- cGMP biopharmaceutical manufacturing and scale-up
- Immunoassay and antibody development
- Custom chemical and reagent manufacturing
Key Technologies
- Lipid nanoparticles
- Ionizable and PEGylated lipids
- Functionalized and isotopically labeled lipids
- Nanobody and antibody production
News & Updates
Announcement of acquisition of a company that develops high-throughput enzymatic and biochemical assays; cited as a January 2025 acquisition and described as expanding assay capabilities.
Announcement of acquisition described as adding specialty lipids and lipid-nanoparticle capabilities to the platform.
Announcement of acquisition of an immunoassay-development company, cited as expanding diagnostic and immunoassay product capabilities.
Press release announcing appointment of a senior executive to lead corporate development and M&A.
Announcement of acquisition of a company that develops high-throughput enzymatic and biochemical assays; cited as a January 2025 acquisition and described as expanding assay capabilities.
Announcement of acquisition described as adding specialty lipids and lipid-nanoparticle capabilities to the platform.
Announcement of acquisition of an immunoassay-development company, cited as expanding diagnostic and immunoassay product capabilities.
Press release announcing appointment of a senior executive to lead corporate development and M&A.